312 related articles for article (PubMed ID: 18524993)
1. Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks.
Sallmyr A; Tomkinson AE; Rassool FV
Blood; 2008 Aug; 112(4):1413-23. PubMed ID: 18524993
[TBL] [Abstract][Full Text] [Related]
2. BCR/ABL stimulates WRN to promote survival and genomic instability.
Slupianek A; Poplawski T; Jozwiakowski SK; Cramer K; Pytel D; Stoczynska E; Nowicki MO; Blasiak J; Skorski T
Cancer Res; 2011 Feb; 71(3):842-51. PubMed ID: 21123451
[TBL] [Abstract][Full Text] [Related]
3. Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias.
Tobin LA; Robert C; Rapoport AP; Gojo I; Baer MR; Tomkinson AE; Rassool FV
Oncogene; 2013 Apr; 32(14):1784-93. PubMed ID: 22641215
[TBL] [Abstract][Full Text] [Related]
4. Cells expressing FLT3/ITD mutations exhibit elevated repair errors generated through alternative NHEJ pathways: implications for genomic instability and therapy.
Fan J; Li L; Small D; Rassool F
Blood; 2010 Dec; 116(24):5298-305. PubMed ID: 20807885
[TBL] [Abstract][Full Text] [Related]
5. Werner protein cooperates with the XRCC4-DNA ligase IV complex in end-processing.
Kusumoto R; Dawut L; Marchetti C; Wan Lee J; Vindigni A; Ramsden D; Bohr VA
Biochemistry; 2008 Jul; 47(28):7548-56. PubMed ID: 18558713
[TBL] [Abstract][Full Text] [Related]
6. c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-Activated Leukemias.
Muvarak N; Kelley S; Robert C; Baer MR; Perrotti D; Gambacorti-Passerini C; Civin C; Scheibner K; Rassool FV
Mol Cancer Res; 2015 Apr; 13(4):699-712. PubMed ID: 25828893
[TBL] [Abstract][Full Text] [Related]
7. Targeting FEN1 Suppresses the Proliferation of Chronic Myeloid Leukemia Cells Through Regulating Alternative End-Joining Pathways.
Zhu Y; Dai H; Wang Y; Liang Y; Feng W; Yuan Y
DNA Cell Biol; 2021 Aug; 40(8):1101-1111. PubMed ID: 34156283
[TBL] [Abstract][Full Text] [Related]
8. Human Mre11/human Rad50/Nbs1 and DNA ligase IIIalpha/XRCC1 protein complexes act together in an alternative nonhomologous end joining pathway.
Della-Maria J; Zhou Y; Tsai MS; Kuhnlein J; Carney JP; Paull TT; Tomkinson AE
J Biol Chem; 2011 Sep; 286(39):33845-53. PubMed ID: 21816818
[TBL] [Abstract][Full Text] [Related]
9. Structure and function of the DNA ligases encoded by the mammalian LIG3 gene.
Tomkinson AE; Sallmyr A
Gene; 2013 Dec; 531(2):150-7. PubMed ID: 24013086
[TBL] [Abstract][Full Text] [Related]
10. Role for Artemis nuclease in the repair of radiation-induced DNA double strand breaks by alternative end joining.
Moscariello M; Wieloch R; Kurosawa A; Li F; Adachi N; Mladenov E; Iliakis G
DNA Repair (Amst); 2015 Jul; 31():29-40. PubMed ID: 25973742
[TBL] [Abstract][Full Text] [Related]
11. DNA ligase IV and artemis act cooperatively to suppress homologous recombination in human cells: implications for DNA double-strand break repair.
Kurosawa A; Saito S; So S; Hashimoto M; Iwabuchi K; Watabe H; Adachi N
PLoS One; 2013; 8(8):e72253. PubMed ID: 23967291
[TBL] [Abstract][Full Text] [Related]
12. Human DNA ligases I and III, but not ligase IV, are required for microhomology-mediated end joining of DNA double-strand breaks.
Liang L; Deng L; Nguyen SC; Zhao X; Maulion CD; Shao C; Tischfield JA
Nucleic Acids Res; 2008 Jun; 36(10):3297-310. PubMed ID: 18440984
[TBL] [Abstract][Full Text] [Related]
13. RAG enhances BCR-ABL1-positive leukemic cell growth through its endonuclease activity in vitro and in vivo.
Yuan M; Wang Y; Qin M; Zhao X; Chen X; Li D; Miao Y; Otieno Odhiambo W; Liu H; Ma Y; Ji Y
Cancer Sci; 2021 Jul; 112(7):2679-2691. PubMed ID: 33949040
[TBL] [Abstract][Full Text] [Related]
14. Requirement for Parp-1 and DNA ligases 1 or 3 but not of Xrcc1 in chromosomal translocation formation by backup end joining.
Soni A; Siemann M; Grabos M; Murmann T; Pantelias GE; Iliakis G
Nucleic Acids Res; 2014 Jun; 42(10):6380-92. PubMed ID: 24748665
[TBL] [Abstract][Full Text] [Related]
15. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways.
Wang M; Wu W; Wu W; Rosidi B; Zhang L; Wang H; Iliakis G
Nucleic Acids Res; 2006; 34(21):6170-82. PubMed ID: 17088286
[TBL] [Abstract][Full Text] [Related]
16. Genetic Variants That Predispose to DNA Double-Strand Breaks in Lymphocytes From a Subset of Patients With Familial Colorectal Carcinomas.
Arora S; Yan H; Cho I; Fan HY; Luo B; Gai X; Bodian DL; Vockley JG; Zhou Y; Handorf EA; Egleston BL; Andrake MD; Nicolas E; Serebriiskii IG; Yen TJ; Hall MJ; Golemis EA; Enders GH
Gastroenterology; 2015 Dec; 149(7):1872-1883.e9. PubMed ID: 26344056
[TBL] [Abstract][Full Text] [Related]
17. Genomic instability in myeloid malignancies: increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair.
Sallmyr A; Fan J; Rassool FV
Cancer Lett; 2008 Oct; 270(1):1-9. PubMed ID: 18467025
[TBL] [Abstract][Full Text] [Related]
18. Werner syndrome helicase has a critical role in DNA damage responses in the absence of a functional fanconi anemia pathway.
Aggarwal M; Banerjee T; Sommers JA; Iannascoli C; Pichierri P; Shoemaker RH; Brosh RM
Cancer Res; 2013 Sep; 73(17):5497-507. PubMed ID: 23867477
[TBL] [Abstract][Full Text] [Related]
19. BCR/ABL downregulates DNA-PK(CS)-dependent and upregulates backup non-homologous end joining in leukemic cells.
Poplawski T; Blasiak J
Mol Biol Rep; 2010 Jun; 37(5):2309-15. PubMed ID: 19697154
[TBL] [Abstract][Full Text] [Related]
20. Perturbed replication induced genome wide or at common fragile sites is differently managed in the absence of WRN.
Murfuni I; De Santis A; Federico M; Bignami M; Pichierri P; Franchitto A
Carcinogenesis; 2012 Sep; 33(9):1655-63. PubMed ID: 22689923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]